Emotra AB Interim report January 1 – September 30, 2018
The Board of Directors and the CEO of Emotra AB [...]
Management changes at EMOTRA
Emotra’s CEO announces that he is stepping down. Emotra’s board [...]
EMOTRA announces that a German psychiatric hospital is introducing EDOR
Yesterday, on October 17, 2018, Emotra hosted a training seminar [...]
Important developments for Emotra
Emotra has reached an important stage in its development. A [...]
New publication demonstrates the strength of Emotra’s test, EDOR®
A study conducted by Emotra’s Chief of Research and the [...]
Emotra AB (publ) Interim report January 1 – June 30 2018
The Board and CEO of Emotra AB (publ) hereby present [...]
Emotra is granted a patent in Japan
As we have previously announced, Japan is one of Emotra’s [...]
Emotra focuses on Europe’s largest cities
As we notified in a previous newsletter and our annual [...]
Communiqué from the Annual General Meeting of EMOTRA AB (publ)
The Annual General Meeting of EMOTRA AB (publ) was held [...]
Emotra AB (publ)Interim report January 1 – March 31, 2018
The Board and CEO of Emotra AB (publ) hereby present [...]